SKI Market

A+| A| A-|

Indian Indices

Sensex

72,696.39 -1,836.57
( -2.46%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

51,583.72 -1,788.81
(-3.35%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

62.6776943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

58.44

2953.82

EPS(TTM)

Face Value()

Div & Yield %

5.04

0.03

Back

kiocl ltd

AGI Greenpac standalone net profit rises 5.60% in the September 2025 quarter

Oct 20,2025

Net profit of AGI Greenpac rose 5.60% to Rs 76.12 crore in the quarter ended September 2025 as against Rs 72.08 crore during the previous quarter ended September 2024. Sales rose 0.40% to Rs 601.58 crore in the quarter ended September 2025 as against Rs 599.18 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	601.58	599.18	0
OPM %	24.88	25.74	-
PBDT	143.51	142.82	0
PBT	100.99	95.80	5
NP	76.12	72.08	6

72,696.39 -1,836.57 ( -2.46%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

51,583.72 -1,788.81 (-3.35%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)